Paper · 42882004

Longitudinal Changes in Serum Interleukin-33 Levels During Acute Psychotic Relapse and Clinical Improvement in Schizophrenia: An Admission-Discharge Study.

Morera-Fumero AL and 5 others. J Clin Med, 2026.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Longitudinal Changes in Serum Interleukin-33 Levels During Acute Psychotic Relapse and Clinical Improvement in Schizophrenia: An Admission-Discharge Study. Papers, record 42882004. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42882004

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Longitudinal Changes in Serum Interleukin-33 Levels During Acute Psychotic Relapse and Clinical Improvement in Schizophrenia: An Admission-Discharge Study.
Journal: J Clin Med
Year: 2026
Publication types: Journal Article
PubMed: https://pubmed.ncbi.nlm.nih.gov/42882004/
DOI: https://doi.org/10.3390/jcm15197542
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13666041/
The journal: https://conductscience.org/library/journal-index/101606588
Revised in PubMed: 2026-10-20

Source PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Morera-Fumero AL	Armando L	https://orcid.org/0000-0002-7663-1154
2	Tascón-Cervera JJ	José J	https://orcid.org/0000-0002-5503-3948
3	Diaz-Mesa E	Estefania
4	Yelmo-Cruz S	Silvia
5	Abreu-González P	Pedro
6	Fernandez-Lopez ML	María Lourdes

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
PI 08/115	Fundacion Canaria para la Investigacion (FUNCIS)			PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	29,705,005	Plasma cytokines in minimally treated schizophrenia.	Schizophr Res	2018	https://conductscience.org/library/papers/29705005	PubMed
2	32,615,087	Microglial Remodeling of the Extracellular Matrix Promotes Synapse Plasticity.	Cell	2020	https://conductscience.org/library/papers/32615087	PubMed
3	28,126,482	Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia.	Compr Psychiatry	2017	https://conductscience.org/library/papers/28126482	PubMed
4	27,844,019	Analysis of IL-33 gene polymorphism (rs11792633 C/T) and risk of schizophrenia.	Mol Biol Res Commun	2016	https://conductscience.org/library/papers/27844019	PubMed
5	31,084,291	Predictors of Hospitalization of Individuals With First-Episode Psychosis: Data From a 2-Year Follow-Up of the RAISE-ETP.	Psychiatr Serv	2019	https://conductscience.org/library/papers/31084291	PubMed
6	19,290,843	Stability of selected serum proteins after long-term storage in the Janus Serum Bank.	Clin Chem Lab Med	2009	https://conductscience.org/library/papers/19290843	PubMed
7	24,373,927	High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serum.	Clin Biochem	2014	https://conductscience.org/library/papers/24373927	PubMed
8	7,810,373	[Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients].	Actas Luso Esp Neurol Psiquiatr Cienc Afines	1994	https://conductscience.org/library/papers/7810373	PubMed
9	30,515,150	Expression and Function of IL-33/ST2 Axis in the Central Nervous System Under Normal and Diseased Conditions.	Front Immunol	2018	https://conductscience.org/library/papers/30515150	PubMed
10	41,270,693	The relationship between serum Interleukin- 6, Interleukin- 18, Interleukin- 2, Eotaxin-1, Monocyte Chemoattractant Protein 1 levels and cognitive functions in treatment-resistant schizophrenia.	Psychiatry Res	2026	https://conductscience.org/library/papers/41270693	PubMed

1 to 10 of 32

See all 32 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42882004

GET https://conductscience.org/api/papers/v1/42882004/references?page=2

API reference For AI assistants